wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50116255-113B6A5C-44C7-4F8F-8F9B-8ED598D70A68
Q50116255-113B6A5C-44C7-4F8F-8F9B-8ED598D70A68
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50116255-113B6A5C-44C7-4F8F-8F9B-8ED598D70A68
Talimogene Laherparepvec: First in Class Oncolytic Virotherapy.
P2860
Q50116255-113B6A5C-44C7-4F8F-8F9B-8ED598D70A68
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50116255-113B6A5C-44C7-4F8F-8F9B-8ED598D70A68
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b04ba680bd1fa30c74982cddf16478f7a578bdbd
P2860
Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial